1. ACH's common stock begins trading under the ticker 'ACH' today. 2. The company launched a new website to enhance its online presence. 3. ACH completed the sale of its former Products & Healthcare Services business. 4. Accendra Health supports patients with chronic health conditions through innovative solutions. 5. Company's future performance is uncertain due to various market risks.
FAQ
Why Bullish?
Trading under a new ticker can attract investor interest, similar to past cases where rebranding led to price spikes. The sale of non-core assets may streamline operations and enhance profitability over time.
How important is it?
The launch of a new ticker and website suggests strategic shifts that could attract investors, though complexities in integrating new assets may temper optimism.
Why Long Term?
The establishment of brand identity and website may enhance customer engagement and retention, leading to sustained growth in the future.
Accendra Health, Inc. (NYSE:ACH) (the "Company") announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, "ACH", effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand.
Safe Harbor
This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain "forward looking" statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the statements in this release regarding our future prospects and performance, including our expectations with respect to our financial performance, our 2025 financial results, our expectations regarding the performance of our business following the completion of the sale of the Products & Healthcare Services business, our cost saving initiatives, future indebtedness and growth, industry trends, as well as statements related to our expectations regarding the performance of our business, including our ability to address macro and market conditions. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 28, 2025, including the section captioned "Item 1A. Risk Factors," as applicable, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the Company's actual results to differ materially from its current estimates. These filings are available at www.accendrahealth.com. Given these risks and uncertainties, The Company can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, cautions investors not to place undue reliance on them. The Company specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
About Accendra Health, Inc.
Accendra Health, Inc. (NYSE:ACH) is a leading nationwide provider of products, technology and services that support health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology and ostomy, visit www.accendrahealth.com.
ACH-CORP
ACH-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20260102331480/en/
Investors
Will Parrish
Vice President | Strategy, Corporate Development, & Investor Relations
Investor.Relations@accendra.com
Media
Darla Turner
Media@accendra.com